Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Psoas sheath block versus suprainguinal fascia iliaca block for pain after hip replacement

Official title: Evaluating the Efficacy of the Psoas Sheath Block for Post Operative Analgesia Following Hip Arthroplasty

Run by University College Hospital Galway · NCT07453498 · Data updated 2026-11-12

This trial will test whether a psoas sheath block provides better pain relief than a suprainguinal fascia iliaca plane block for adults having elective total hip replacement.

More Total Hip Arthroplasty (THA) trials

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment130 (estimated)
SponsorUniversity College Hospital Galway
Academic / other
Locations1 site (Galway)
StatusRecruiting
StartedNovember 18, 2025
Main results expectedNovember 18, 2027
Study endsNovember 18, 2027
Registry record updatedMarch 6, 2026
Trial IDNCT07453498 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults over 18 scheduled for elective unilateral total hip replacement who are ASA I-III, willing to receive regional anaesthesia, and able to provide informed consent are eligible.

Probably not a fit

Patients with allergy to study medications, chronic high-dose opioid use, active infection at the injection site, coagulopathy or on anticoagulants, or neurological conditions affecting the lower limbs are unlikely to benefit or be eligible.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This single-centre, assessor-blind, randomized controlled trial at Merlin Park Hospital, Galway will compare two regional anaesthesia techniques for postoperative analgesia after elective unilateral total hip arthroplasty. Participants will be randomly assigned to receive either a psoas sheath block (experimental) or a suprainguinal fascia iliaca plane block (control) with allocation concealed in opaque sealed envelopes. The outcome assessor will be blinded to group allocation and common outcomes will include postoperative pain scores and opioid consumption. The trial focuses on adults (ASA I-III) willing to receive regional blocks and provide informed consent.

Why it matters

Potential benefit: If successful, the psoas sheath block could provide better pain control and reduce opioid use after hip replacement, potentially improving recovery and mobility.

How similar studies have gone: Regional blocks such as fascia iliaca and psoas compartment techniques have been shown to reduce pain and opioid need after hip surgery, but direct comparisons between psoas sheath and suprainguinal fascia iliaca blocks are limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Participants aged \>18
* Patients scheduled to undergo elective unilateral total hip replacement (THR) surgery.
* Patients who agree to receive regional anaesthetic blocks as part of their post-operative pain management.
* Physical Status: ASA (American Society of Anesthesiologists) physical status classification I-III.
* Patients who are willing and able to provide informed consent, demonstrating an understanding of the trial's purpose, methods, and potential risks.
* Patients who are willing to comply with assessments post-surgery

Exclusion Criteria:

* Allergy to Study Medications
* History of chronic opioid use (\>50mg of oral morphine equivalents per day.
* Any neurological condition affecting the lower extremities (e.g., peripheral neuropathy, radiculopathy) that could interfere with pain assessment or recovery evaluation.
* Infection at Injection Site
* Coagulopathy or Anticoagulant Use: Patients with coagulopathy (INR \>1.5) or who are on anticoagulant therapy that cannot be safely discontinued for the block procedure.
* Severe Respiratory or Cardiovascular Disease: Any severe respiratory or cardiovascular disease (e.g., severe chronic obstructive pulmonary disease, heart failure) that may increase perioperative risk and complicate recovery.
* Cognitive impairment or conditions (e.g., dementia with MMSE \<24) that would prevent reliable pain reporting or compliance with post-operative assessments

Where it's running

  • Merlin Park Hospital, Galway
    Galway, Ireland
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.